Structure |
Chemical Name |
CAS |
MF |
![Parent nucleus of cefotiaM hydrochloride](/CAS/20180808/GIF/372092-19-8.gif) |
Parent nucleus of cefotiaM hydrochloride |
372092-19-8 |
C13H21N7O3S2 |
![Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)](/CAS/20150408/GIF/111664-35-8.gif) |
Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) |
111664-35-8 |
C22H19NO4 |
![6-(2,5-dichlorophenyl)-1,3,5-Triazine-2,4(1H,3H)-dione](/CAS/GIF/30222-00-5.gif) |
6-(2,5-dichlorophenyl)-1,3,5-Triazine-2,4(1H,3H)-dione |
30222-00-5 |
C9H5Cl2N3O2 |
![ウリジン, 2'-デオキシ-2'-フルオロ-2'-メチル-, '3',5'-二安息香酸, (2'R)-](/CAS/GIF/863329-65-1.gif) |
ウリジン, 2'-デオキシ-2'-フルオロ-2'-メチル-, '3',5'-二安息香酸, (2'R)- |
863329-65-1 |
C24H21FN2O7 |
![Celecoxib iMpurity-A](/) |
Celecoxib iMpurity-A |
|
|
![EMtricitabine iMpurity A](/) |
EMtricitabine iMpurity A |
|
|
![RocuroniuMbroMide iMpurity D](/) |
RocuroniuMbroMide iMpurity D |
|
|
![(3S,4R)-4-(4-Fluorophenyl)piperidine-3-Methanol Hydrochloride](/CAS/GIF/220548-73-2.gif) |
(3S,4R)-4-(4-Fluorophenyl)piperidine-3-Methanol Hydrochloride |
220548-73-2 |
C12H17ClFNO |
![LaMotrigine IMpurity D](/CAS/GIF/661463-79-2.gif) |
LaMotrigine IMpurity D |
661463-79-2 |
C9H5Cl2N3O2 |
![デメチルピペラジニルデスエチルシルデナフィルスルホニルクロリド](/CAS/GIF/139756-27-7.gif) |
デメチルピペラジニルデスエチルシルデナフィルスルホニルクロリド |
139756-27-7 |
C15H15ClN4O4S |
![Rizatriptan IMpurity B](/CAS/GIF/1016900-28-9.gif) |
Rizatriptan IMpurity B |
1016900-28-9 |
C13H15ClN5 |
![rac Adrenaline IMpurity D](/CAS/GIF/1095714-91-2.gif) |
rac Adrenaline IMpurity D |
1095714-91-2 |
C16H19NO3 |
![2-イソプロペニル-6-イソプロピルフェノール](/CAS/GIF/74926-89-9.gif) |
2-イソプロペニル-6-イソプロピルフェノール |
74926-89-9 |
C12H16O |
![Irinotecan IMpurity G](/CAS/GIF/947687-02-7.gif) |
Irinotecan IMpurity G |
947687-02-7 |
C35H42N4O6 |
![ジヒドロキシベンダムスチン](/CAS/GIF/109882-30-6.gif) |
ジヒドロキシベンダムスチン |
109882-30-6 |
C16H23N3O4 |
![5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide](/CAS/GIF/325855-74-1.gif) |
5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide |
325855-74-1 |
C18H15ClN2O3S |
![Lafutidine IMpuritiy B](/CAS/20150408/GIF/174583-84-7.gif) |
Lafutidine IMpuritiy B |
174583-84-7 |
C22H29N3O5S |
![N,N-ジメシル-2-フェノキシアニリン](/CAS/GIF/905858-63-1.gif) |
N,N-ジメシル-2-フェノキシアニリン |
905858-63-1 |
C14H15NO5S2 |
![3-Pyrrolidinepropanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-, (αS,3S)-](/CAS/20211123/GIF/741267-75-4.gif) |
3-Pyrrolidinepropanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-, (αS,3S)- |
741267-75-4 |
C12H20N2O5 |
![Topiroxostat Impurity 44](/CAS/20211123/GIF/1824131-48-7.gif) |
Topiroxostat Impurity 44 |
1824131-48-7 |
C7H6N4O |
![Fexofenadine Impurity 12](/CAS/20210305/GIF/1010812-98-2.gif) |
Fexofenadine Impurity 12 |
1010812-98-2 |
C32H37NO4 |
![2,2'-(oxybis((2-chloro-5-iodophenyl)methylene))diphenol](/CAS/20181212/GIF/CB38117749.gif) |
2,2'-(oxybis((2-chloro-5-iodophenyl)methylene))diphenol |
|
C26H18Cl2I2O3 |
![Gliclazide Impurity 6](/CAS/20210111/GIF/1207714-41-7.gif) |
Gliclazide Impurity 6 |
1207714-41-7 |
C8H10N2O3S |
![Phenol, 4,4'-(4-pyridinylmethylene)bis-](/CAS/20210111/GIF/109810-81-3.gif) |
Phenol, 4,4'-(4-pyridinylmethylene)bis- |
109810-81-3 |
C18H15NO2 |
![4,5-Dihydro-α,3-diMethyl-5-oxo-1-phenyl-α-sulfo-1H-pyrazole-4-acetic Acid](/CAS/GIF/1357477-99-6.gif) |
4,5-Dihydro-α,3-diMethyl-5-oxo-1-phenyl-α-sulfo-1H-pyrazole-4-acetic Acid |
1357477-99-6 |
C13H14N2O6S |
![tert-butyl 4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoyl)piperazine-1-carboxylate](/CAS/GIF/763114-04-1.gif) |
tert-butyl 4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoyl)piperazine-1-carboxylate |
763114-04-1 |
C25H27FN4O4 |
![1H-IMidazole, 4-Methyl-1-[3-nitro-5-(trifluoroMethyl)phenyl]-](/CAS/GIF/916975-92-3.gif) |
1H-IMidazole, 4-Methyl-1-[3-nitro-5-(trifluoroMethyl)phenyl]- |
916975-92-3 |
C11H8F3N3O2 |
![2-(3-メチル-5-オキソ-1-フェニル-4,5-ジヒドロ-1H-ピラゾール-4-イル)プロパン-2-スルホン酸](/CAS/20150408/GIF/1323485-71-7.gif) |
2-(3-メチル-5-オキソ-1-フェニル-4,5-ジヒドロ-1H-ピラゾール-4-イル)プロパン-2-スルホン酸 |
1323485-71-7 |
C13H16N2O4S |
![Ondansetron Impurity B](/) |
Ondansetron Impurity B |
|
|
![LeflunoMide EP IMpurity F](/CAS/20210111/GIF/1403564-06-6.gif) |
LeflunoMide EP IMpurity F |
1403564-06-6 |
C12H9F3N2O2 |
![4'-((1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl)biphenyl-2-carboxylic acid](/) |
4'-((1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl)biphenyl-2-carboxylic acid |
|
|
![Itraconazole iMpurity D](/) |
Itraconazole iMpurity D |
|
|
![3-amino-2-chloroacrolein](/CAS/GIF/221615-73-2.gif) |
3-amino-2-chloroacrolein |
221615-73-2 |
C3H4ClNO |
![3-アミノ-4-ピラゾールカルボニトリル](/CAS/GIF/16617-46-2.gif) |
3-アミノ-4-ピラゾールカルボニトリル |
16617-46-2 |
C4H4N4 |
![BenzaMide, 3,4-bis(cyclopropylMethoxy)-N-(3,5-dichloro-4-pyridinyl)-](/CAS/GIF/1391052-24-6.gif) |
BenzaMide, 3,4-bis(cyclopropylMethoxy)-N-(3,5-dichloro-4-pyridinyl)- |
1391052-24-6 |
C20H20Cl2N2O3 |
![1-(4-アセチルフェニル)-2-メチル-1-プロパノン](/CAS/GIF/103931-20-0.gif) |
1-(4-アセチルフェニル)-2-メチル-1-プロパノン |
103931-20-0 |
C12H14O2 |
![ButanaMide, 4-hydroxy-N-(1-Methylethyl)-](/CAS/GIF/42042-66-0.gif) |
ButanaMide, 4-hydroxy-N-(1-Methylethyl)- |
42042-66-0 |
C7H15NO2 |
![5H-chroMeno[2,3-b]pyridin-7-ylacetic acid](/CAS/GIF/52549-07-2.gif) |
5H-chroMeno[2,3-b]pyridin-7-ylacetic acid |
52549-07-2 |
C14H11NO3 |
![IMp. B (EP): (2RS,4S)-2-[[[[3-(2-Chloro-6-fluorophenyl)-5-Methylisoxazol-4-yl]carbonyl]aMino]Methyl]-5,5-diMethyl- thiazolidine-4-carboxylic Acid (Penilloic Acids of Flucloxacillin)](/) |
IMp. B (EP): (2RS,4S)-2-[[[[3-(2-Chloro-6-fluorophenyl)-5-Methylisoxazol-4-yl]carbonyl]aMino]Methyl]-5,5-diMethyl- thiazolidine-4-carboxylic Acid (Penilloic Acids of Flucloxacillin) |
|
|
![IMp. C (EP): (4-(DiphenylMethyl)-1,1-bis[(E)-3-phenylprop-2-enyl]piperaziniuM Chloride](/CAS/20211123/GIF/95062-18-3.gif) |
IMp. C (EP): (4-(DiphenylMethyl)-1,1-bis[(E)-3-phenylprop-2-enyl]piperaziniuM Chloride |
95062-18-3 |
C35H35ClF2N2 |
![IMp. E (EP): 4-AMino-5-(ethylsulphonyl)-2-Methoxybenzoic Acid](/) |
IMp. E (EP): 4-AMino-5-(ethylsulphonyl)-2-Methoxybenzoic Acid |
|
|
![1-ニトロ-3,7-ジメチルアダマンタン](/CAS/20150408/GIF/6588-68-7.gif) |
1-ニトロ-3,7-ジメチルアダマンタン |
6588-68-7 |
C12H19NO2 |
![6-O-Benzyl-4-dehydroxy-4-diMethylphenylsilyl Entecavir](/CAS/GIF/649761-24-0.gif) |
6-O-Benzyl-4-dehydroxy-4-diMethylphenylsilyl Entecavir |
649761-24-0 |
C27H31N5O2Si |
![Desisobutyl-n-butyl BortezoMib](/CAS/GIF/1104011-35-9.gif) |
Desisobutyl-n-butyl BortezoMib |
1104011-35-9 |
C19H25BN4O4 |
![2-aMino-4-Methoxy-5-(3-Morpholinopropoxy)benzaMide](/CAS/20150408/GIF/246512-44-7.gif) |
2-aMino-4-Methoxy-5-(3-Morpholinopropoxy)benzaMide |
246512-44-7 |
C15H23N3O4 |
![N-(4,6-dichloro-2-(propylthio)pyriMidin-5-yl)forMaMide](/CAS/20150408/GIF/1402150-28-0.gif) |
N-(4,6-dichloro-2-(propylthio)pyriMidin-5-yl)forMaMide |
1402150-28-0 |
C8H9Cl2N3OS |
![Ebastine IMpurity G](/CAS/20200611/GIF/1429071-65-7.gif) |
Ebastine IMpurity G |
1429071-65-7 |
C32H39NO3 |
![((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid](/CAS/GIF/1132709-15-9.gif) |
((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid |
1132709-15-9 |
C19H25BN4O4 |
![N-[(1S)-2-アミノ-2-オキソ-1-(フェニルメチル)エチル]-2-ピラジンカルボキサミド](/CAS/GIF/289472-80-6.gif) |
N-[(1S)-2-アミノ-2-オキソ-1-(フェニルメチル)エチル]-2-ピラジンカルボキサミド |
289472-80-6 |
C14H14N4O2 |
![(3aS,4R,6S,6aR)-6-AMinotetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-ol](/CAS/20150408/GIF/592533-90-9.gif) |
(3aS,4R,6S,6aR)-6-AMinotetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-ol |
592533-90-9 |
C8H15NO3 |
![(1R,2R,3S,5R)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20150408/GIF/CB62664138.gif) |
(1R,2R,3S,5R)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
2096989-55-6 |
C23H28F2N6O4S |
![Rivaroxaban iMpurity](/CAS/20200515/GIF/1616563-62-2.gif) |
Rivaroxaban iMpurity |
1616563-62-2 |
C15H17N3O5 |
![cefoxitin iMpurity D](/) |
cefoxitin iMpurity D |
|
|
![3-Morpholinone, 4-(2,4-diaMinophenyl)-](/CAS/20150408/GIF/482308-13-4.gif) |
3-Morpholinone, 4-(2,4-diaMinophenyl)- |
482308-13-4 |
C10H13N3O2 |
![Ropivacaine Impurity 50](/) |
Ropivacaine Impurity 50 |
|
|
![Glycine, N-[(4,7-dihydroxy-1-methyl-3-isoquinolinyl)carbonyl]-](/CAS/20210111/GIF/2173338-12-8.gif) |
Glycine, N-[(4,7-dihydroxy-1-methyl-3-isoquinolinyl)carbonyl]- |
2173338-12-8 |
C13H12N2O5 |
![5-Thiazolecarboxylic acid, 2-[3,5-diformyl-4-(2-methylpropoxy)phenyl]-4-methyl-, ethyl ester](/CAS/20200611/GIF/2375033-26-2.gif) |
5-Thiazolecarboxylic acid, 2-[3,5-diformyl-4-(2-methylpropoxy)phenyl]-4-methyl-, ethyl ester |
2375033-26-2 |
C19H21NO5S |
![Furosemide Impurity 6](/CAS/20210111/GIF/74793-12-7.gif) |
Furosemide Impurity 6 |
74793-12-7 |
C12H10ClNO3 |
![Lumateperone Impurity 3](/CAS/20210111/GIF/313544-76-2.gif) |
Lumateperone Impurity 3 |
313544-76-2 |
C17H21N3O3 |
![Butanoic acid, L-2-aminobutanoyl-L-2-amino-, methyl ester (9CI)](/CAS/20210305/GIF/772292-30-5.gif) |
Butanoic acid, L-2-aminobutanoyl-L-2-amino-, methyl ester (9CI) |
772292-30-5 |
C9H18N2O3 |
![Hexanoic acid, 3-(hydroxymethyl)-, (3R)-](/CAS/20210111/GIF/2096999-79-8.gif) |
Hexanoic acid, 3-(hydroxymethyl)-, (3R)- |
2096999-79-8 |
C7H14O3 |
![2-(((Z)-(1-(2-aminothiazol-4-yl)-2-(((2S,3S)-1-(ethoxysulfonyl)-2-methyl-4-oxoazetidin-3-yl)amino)-2-oxoethylidene)amino)oxy)-2-methylpropanoic acid](/) |
2-(((Z)-(1-(2-aminothiazol-4-yl)-2-(((2S,3S)-1-(ethoxysulfonyl)-2-methyl-4-oxoazetidin-3-yl)amino)-2-oxoethylidene)amino)oxy)-2-methylpropanoic acid |
|
|
![3-Thiophenecarboxylic acid, 4-formyl-2,5-dihydro-2-(4-hydroxybutylidene)-5-methyl-, (2Z)-](/CAS/20210111/GIF/1025974-23-5.gif) |
3-Thiophenecarboxylic acid, 4-formyl-2,5-dihydro-2-(4-hydroxybutylidene)-5-methyl-, (2Z)- |
1025974-23-5 |
C11H14O4S |
![1H-Pyrrole-3-methanamine, 1-[(1,4-dihydro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)-N-methyl-](/CAS/20200611/GIF/2416241-98-8.gif) |
1H-Pyrrole-3-methanamine, 1-[(1,4-dihydro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)-N-methyl- |
2416241-98-8 |
C17H18FN3O2S |
![impurity 44](/) |
impurity 44 |
|
|
![3-((2-acetamido-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)propane- 1,2-diyl diacetate](/) |
3-((2-acetamido-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)propane- 1,2-diyl diacetate |
96429-68-4 |
|
![L-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, γ-lactone, 3,5-dibenzoate, (2S)-](/CAS/20210305/GIF/1946820-91-2.gif) |
L-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, γ-lactone, 3,5-dibenzoate, (2S)- |
1946820-91-2 |
C20H17FO6 |
![5,5'-Bi-1H-benzimidazole, 6,6'-bis(difluoromethoxy)-2,2'-bis[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-](/CAS/20200611/GIF/2251784-93-5.gif) |
5,5'-Bi-1H-benzimidazole, 6,6'-bis(difluoromethoxy)-2,2'-bis[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]- |
2251784-93-5 |
C32H28F4N6O6S2 |
![1,4,7,10-Tetraazacyclododecane-1,7-diacetic acid, 4,10-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-](/CAS/20200611/GIF/2514736-58-2.gif) |
1,4,7,10-Tetraazacyclododecane-1,7-diacetic acid, 4,10-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]- |
2514736-58-2 |
C20H40N4O10 |
![Valsartan Methyl Ester N2-Trityl Analog](/CAS/20200611/GIF/883223-10-7.gif) |
Valsartan Methyl Ester N2-Trityl Analog |
883223-10-7 |
C44H45N5O3 |
![Ampicillin Impurity G](/) |
Ampicillin Impurity G |
|
|
![N-(5-((diphenylphosphoryl)methyl)-4-(3-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide](/) |
N-(5-((diphenylphosphoryl)methyl)-4-(3-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide |
|
|
![Budesonide Impurity 28](/) |
Budesonide Impurity 28 |
|
|
![Ethanol, 2-[2-(2-methyl-4-nitro-1H-imidazol-1-yl)ethoxy]-](/CAS/20210111/GIF/19765-12-9.gif) |
Ethanol, 2-[2-(2-methyl-4-nitro-1H-imidazol-1-yl)ethoxy]- |
19765-12-9 |
C8H13N3O4 |
![INDEX NAME NOT YET ASSIGNED](/CAS/20211123/GIF/2452301-30-1.gif) |
INDEX NAME NOT YET ASSIGNED |
2452301-30-1 |
C23H27ClO7 |
![(5R,6S)-6-((R)-1-hydroxyethyl)-7-oxo-3-((S)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4,4-dioxide](/) |
(5R,6S)-6-((R)-1-hydroxyethyl)-7-oxo-3-((S)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4,4-dioxide |
|
|
![(3S,5R,6E) Rosuvastatin Calcium Salt (2:1)](/CAS/20210111/GIF/2414245-11-5.gif) |
(3S,5R,6E) Rosuvastatin Calcium Salt (2:1) |
2414245-11-5 |
C22H30CaFN3O6S |
![INDEX NAME NOT YET ASSIGNED](/CAS/20211123/GIF/2452301-42-5.gif) |
INDEX NAME NOT YET ASSIGNED |
2452301-42-5 |
C23H27ClO7 |
![2'-アミノ-2-フルオロベンゾフェノン](/CAS/GIF/1581-13-1.gif) |
2'-アミノ-2-フルオロベンゾフェノン |
1581-13-1 |
C13H10FNO |
![(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium](/CAS/20210111/GIF/2480467-84-1.gif) |
(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium |
2480467-84-1 |
C28H35NO7S |
![2-アミノ-4-メチル-6-(3-ピリジル)ピリミジン](/CAS/GIF/90916-52-2.gif) |
2-アミノ-4-メチル-6-(3-ピリジル)ピリミジン |
90916-52-2 |
C10H10N4 |
![1-ベンジル-4-(5,6-ジメトキシ-1-オキソインダン-2-Yリンデンメチル)ピペリジン](/CAS/GIF/120014-07-5.gif) |
1-ベンジル-4-(5,6-ジメトキシ-1-オキソインダン-2-Yリンデンメチル)ピペリジン |
120014-07-5 |
C24H27NO3 |
![Crisaborole Impurity 16](/CAS/20211123/GIF/2268785-42-6.gif) |
Crisaborole Impurity 16 |
2268785-42-6 |
C14H10BNO3 |
![グアニジン](/CAS/GIF/113-00-8.gif) |
グアニジン |
113-00-8 |
CH5N3 |
![(3R,5S)-フルバスタチンTERT-ブチルエステル](/CAS/GIF/194934-96-8.gif) |
(3R,5S)-フルバスタチンTERT-ブチルエステル |
194934-96-8 |
C28H34FNO4 |
![Brivaracetam Impurity 55](/) |
Brivaracetam Impurity 55 |
|
|
![α-(4-クロロフェニル)-α-[2-(ジメチルアミノ)エチル]-2-ピリジンアセトニトリル](/CAS/GIF/65676-21-3.gif) |
α-(4-クロロフェニル)-α-[2-(ジメチルアミノ)エチル]-2-ピリジンアセトニトリル |
65676-21-3 |
C17H18ClN3 |
![Baloxavir Impurity ABCDEFGHJKL](/) |
Baloxavir Impurity ABCDEFGHJKL |
|
|
![INDEX NAME NOT YET ASSIGNED](/CAS/20211123/GIF/2514724-36-6.gif) |
INDEX NAME NOT YET ASSIGNED |
2514724-36-6 |
C22H19F2N3 |
![スコポリン](/CAS/GIF/487-27-4.gif) |
スコポリン |
487-27-4 |
C8H13NO2 |
![N-[1-(1-ベンジル-2-フェニルエチル)-4-ピペリジニル]-N-フェニルプロパンアミド](/CAS/GIF/1474-02-8.gif) |
N-[1-(1-ベンジル-2-フェニルエチル)-4-ピペリジニル]-N-フェニルプロパンアミド |
1474-02-8 |
C21H26N2O |
![Oseltamivir Impurity 106](/) |
Oseltamivir Impurity 106 |
|
|
![Oseltamivir Impurity 85](/) |
Oseltamivir Impurity 85 |
|
|
![Oseltamivir Impurity 83](/) |
Oseltamivir Impurity 83 |
|
|
![Oseltamivir Impurity 75](/) |
Oseltamivir Impurity 75 |
|
|
![1,1'-ビ[シクロヘキサン]-1-カルボン酸](/CAS/GIF/60263-54-9.gif) |
1,1'-ビ[シクロヘキサン]-1-カルボン酸 |
60263-54-9 |
C13H22O2 |
![Dapagliflozin Impurity 49](/) |
Dapagliflozin Impurity 49 |
|
|
![6,11-ジヒドロ-11-[3-(ジメチルアミノ)プロピル]ジベンゾ[b,e]オキセピン-11-オール](/CAS/GIF/4504-88-5.gif) |
6,11-ジヒドロ-11-[3-(ジメチルアミノ)プロピル]ジベンゾ[b,e]オキセピン-11-オール |
4504-88-5 |
C19H23NO2 |
![1-(2-クロロエチル)-3-(ジシクロプロピルメチル)尿素](/CAS/GIF/54187-03-0.gif) |
1-(2-クロロエチル)-3-(ジシクロプロピルメチル)尿素 |
54187-03-0 |
C10H17ClN2O |
![3-ヒドロキシ-2,4-ジメトキシベンズアルデヒド](/CAS/GIF/32246-34-7.gif) |
3-ヒドロキシ-2,4-ジメトキシベンズアルデヒド |
32246-34-7 |
C9H10O4 |